American Society for Gastrointestinal Endoscopy–European Society of Gastrointestinal Endoscopy guideline on primary endoscopic bariatric and metabolic therapies for adults with obesity

Pichamol Jirapinyo; Alia Hadefi; Christopher C. Thompson; Árpád V. Patai; Rahul Pannala; Stefan K. Goelder; Vladimir Kushnir; Marc Barthet; Caroline M. Apovian; Ivo Boskoski; Christopher G. Chapman; Paul Davidson; Gianfranco Donatelli; Vivek Kumbhari; Bu Hayee; Janelle Esker; Tomas Hucl; Aurora D. Pryor; Roberta Maselli; Allison R. Schulman; Francois Pattou; Shira Zelber-Sagi; Paul A. Bain; Valérie Durieux; Konstantinos Triantafyllou; Nirav Thosani; Vincent Huberty; Shelby Sullivan

doi:10.1016/j.gie.2023.12.004

American Society for Gastrointestinal Endoscopy–European Society of Gastrointestinal Endoscopy guideline on primary endoscopic bariatric and metabolic therapies for adults with obesity

Pichamol Jirapinyo, Alia Hadefi, Christopher C. Thompson, Árpád V. Patai, Rahul Pannala, Stefan K. Goelder, Vladimir Kushnir, Marc Barthet, Caroline M. Apovian, Ivo Boskoski, Christopher G. Chapman, Paul Davidson, Gianfranco Donatelli, Vivek Kumbhari, Bu Hayee, Janelle Esker, Tomas Hucl, Aurora D. Pryor, Roberta Maselli, Allison R. SchulmanFrancois Pattou, Shira Zelber-Sagi, Paul A. Bain, Valérie Durieux, Konstantinos Triantafyllou, Nirav Thosani, Vincent Huberty, Shelby Sullivan

School of Public Health

University of Haifa

Research output: Contribution to journal › Article › peer-review

Abstract

This joint ASGE-ESGE guideline provides an evidence-based summary and recommendations regarding the role of endoscopic bariatric and metabolic therapies (EBMTs) in the management of obesity. The document was developed using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) framework. It evaluates the efficacy and safety of EBMT devices and procedures that currently have CE mark or FDA-clearance/approval, or that had been approved within five years of document development. The guideline suggests the use of EBMTs plus lifestyle modification in patients with a BMI of ≥ 30 kg/m², or with a BMI of 27.0-29.9 kg/m² with at least 1 obesity-related comorbidity. Furthermore, it suggests the utilization of intragastric balloons and devices for endoscopic gastric remodeling (EGR) in conjunction with lifestyle modification for this patient population.

Original language	American English
Pages (from-to)	867-885.e64
Journal	Gastrointestinal Endoscopy
Volume	99
Issue number	6
DOIs	https://doi.org/10.1016/j.gie.2023.12.004
State	Published - Jun 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

Radiology Nuclear Medicine and imaging
Gastroenterology

Access to Document

10.1016/j.gie.2023.12.004

Cite this

Jirapinyo, P., Hadefi, A., Thompson, C. C., Patai, Á. V., Pannala, R., Goelder, S. K., Kushnir, V., Barthet, M., Apovian, C. M., Boskoski, I., Chapman, C. G., Davidson, P., Donatelli, G., Kumbhari, V., Hayee, B., Esker, J., Hucl, T., Pryor, A. D., Maselli, R., ... Sullivan, S. (2024). American Society for Gastrointestinal Endoscopy–European Society of Gastrointestinal Endoscopy guideline on primary endoscopic bariatric and metabolic therapies for adults with obesity. Gastrointestinal Endoscopy, 99(6), 867-885.e64. https://doi.org/10.1016/j.gie.2023.12.004

@article{b5905d567ba842a3ade517f615b41df9,

title = "American Society for Gastrointestinal Endoscopy–European Society of Gastrointestinal Endoscopy guideline on primary endoscopic bariatric and metabolic therapies for adults with obesity",

abstract = "This joint ASGE-ESGE guideline provides an evidence-based summary and recommendations regarding the role of endoscopic bariatric and metabolic therapies (EBMTs) in the management of obesity. The document was developed using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) framework. It evaluates the efficacy and safety of EBMT devices and procedures that currently have CE mark or FDA-clearance/approval, or that had been approved within five years of document development. The guideline suggests the use of EBMTs plus lifestyle modification in patients with a BMI of ≥ 30 kg/m2, or with a BMI of 27.0-29.9 kg/m2 with at least 1 obesity-related comorbidity. Furthermore, it suggests the utilization of intragastric balloons and devices for endoscopic gastric remodeling (EGR) in conjunction with lifestyle modification for this patient population.",

author = "Pichamol Jirapinyo and Alia Hadefi and Thompson, \{Christopher C.\} and Patai, \{{\'A}rp{\'a}d V.\} and Rahul Pannala and Goelder, \{Stefan K.\} and Vladimir Kushnir and Marc Barthet and Apovian, \{Caroline M.\} and Ivo Boskoski and Chapman, \{Christopher G.\} and Paul Davidson and Gianfranco Donatelli and Vivek Kumbhari and Bu Hayee and Janelle Esker and Tomas Hucl and Pryor, \{Aurora D.\} and Roberta Maselli and Schulman, \{Allison R.\} and Francois Pattou and Shira Zelber-Sagi and Bain, \{Paul A.\} and Val{\'e}rie Durieux and Konstantinos Triantafyllou and Nirav Thosani and Vincent Huberty and Shelby Sullivan",

note = "Publisher Copyright: {\textcopyright} 2024 American Society for Gastrointestinal Endoscopy and European Society of Gastrointestinal Endoscopy. Published by Elsevier Inc on behalf of American Society for Gastrointestinal Endoscopy and by Georg Thieme Verlag KG Stuttgart on behalf of European Society of Gastrointestinal Endoscopy. All rights reserved",

year = "2024",

month = jun,

doi = "10.1016/j.gie.2023.12.004",

language = "American English",

volume = "99",

pages = "867--885.e64",

journal = "Gastrointestinal Endoscopy",

issn = "0016-5107",

publisher = "Elsevier Inc.",

number = "6",

}

Jirapinyo, P, Hadefi, A, Thompson, CC, Patai, ÁV, Pannala, R, Goelder, SK, Kushnir, V, Barthet, M, Apovian, CM, Boskoski, I, Chapman, CG, Davidson, P, Donatelli, G, Kumbhari, V, Hayee, B, Esker, J, Hucl, T, Pryor, AD, Maselli, R, Schulman, AR, Pattou, F, Zelber-Sagi, S, Bain, PA, Durieux, V, Triantafyllou, K, Thosani, N, Huberty, V & Sullivan, S 2024, 'American Society for Gastrointestinal Endoscopy–European Society of Gastrointestinal Endoscopy guideline on primary endoscopic bariatric and metabolic therapies for adults with obesity', Gastrointestinal Endoscopy, vol. 99, no. 6, pp. 867-885.e64. https://doi.org/10.1016/j.gie.2023.12.004

American Society for Gastrointestinal Endoscopy–European Society of Gastrointestinal Endoscopy guideline on primary endoscopic bariatric and metabolic therapies for adults with obesity. / Jirapinyo, Pichamol; Hadefi, Alia; Thompson, Christopher C. et al.
In: Gastrointestinal Endoscopy, Vol. 99, No. 6, 06.2024, p. 867-885.e64.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - American Society for Gastrointestinal Endoscopy–European Society of Gastrointestinal Endoscopy guideline on primary endoscopic bariatric and metabolic therapies for adults with obesity

AU - Jirapinyo, Pichamol

AU - Hadefi, Alia

AU - Thompson, Christopher C.

AU - Patai, Árpád V.

AU - Pannala, Rahul

AU - Goelder, Stefan K.

AU - Kushnir, Vladimir

AU - Barthet, Marc

AU - Apovian, Caroline M.

AU - Boskoski, Ivo

AU - Chapman, Christopher G.

AU - Davidson, Paul

AU - Donatelli, Gianfranco

AU - Kumbhari, Vivek

AU - Hayee, Bu

AU - Esker, Janelle

AU - Hucl, Tomas

AU - Pryor, Aurora D.

AU - Maselli, Roberta

AU - Schulman, Allison R.

AU - Pattou, Francois

AU - Zelber-Sagi, Shira

AU - Bain, Paul A.

AU - Durieux, Valérie

AU - Triantafyllou, Konstantinos

AU - Thosani, Nirav

AU - Huberty, Vincent

AU - Sullivan, Shelby

N1 - Publisher Copyright: © 2024 American Society for Gastrointestinal Endoscopy and European Society of Gastrointestinal Endoscopy. Published by Elsevier Inc on behalf of American Society for Gastrointestinal Endoscopy and by Georg Thieme Verlag KG Stuttgart on behalf of European Society of Gastrointestinal Endoscopy. All rights reserved

PY - 2024/6

Y1 - 2024/6

N2 - This joint ASGE-ESGE guideline provides an evidence-based summary and recommendations regarding the role of endoscopic bariatric and metabolic therapies (EBMTs) in the management of obesity. The document was developed using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) framework. It evaluates the efficacy and safety of EBMT devices and procedures that currently have CE mark or FDA-clearance/approval, or that had been approved within five years of document development. The guideline suggests the use of EBMTs plus lifestyle modification in patients with a BMI of ≥ 30 kg/m2, or with a BMI of 27.0-29.9 kg/m2 with at least 1 obesity-related comorbidity. Furthermore, it suggests the utilization of intragastric balloons and devices for endoscopic gastric remodeling (EGR) in conjunction with lifestyle modification for this patient population.

AB - This joint ASGE-ESGE guideline provides an evidence-based summary and recommendations regarding the role of endoscopic bariatric and metabolic therapies (EBMTs) in the management of obesity. The document was developed using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) framework. It evaluates the efficacy and safety of EBMT devices and procedures that currently have CE mark or FDA-clearance/approval, or that had been approved within five years of document development. The guideline suggests the use of EBMTs plus lifestyle modification in patients with a BMI of ≥ 30 kg/m2, or with a BMI of 27.0-29.9 kg/m2 with at least 1 obesity-related comorbidity. Furthermore, it suggests the utilization of intragastric balloons and devices for endoscopic gastric remodeling (EGR) in conjunction with lifestyle modification for this patient population.

UR - http://www.scopus.com/inward/record.url?scp=85192004059&partnerID=8YFLogxK

U2 - 10.1016/j.gie.2023.12.004

DO - 10.1016/j.gie.2023.12.004

M3 - Article

C2 - 38639680

SN - 0016-5107

VL - 99

SP - 867-885.e64

JO - Gastrointestinal Endoscopy

JF - Gastrointestinal Endoscopy

IS - 6

ER -

American Society for Gastrointestinal Endoscopy–European Society of Gastrointestinal Endoscopy guideline on primary endoscopic bariatric and metabolic therapies for adults with obesity

Abstract

UN SDGs

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this